JPMorgan Chase & Co’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9K | Sell |
10,898
-5,114
| -32% | -$5.57K | ﹤0.01% | 5412 |
|
|
2025
Q1 | $15.6K | Sell |
16,012
-46,916
| -75% | -$45.6K | ﹤0.01% | 5350 |
|
|
2024
Q4 | $93.1K | Buy |
62,928
+49,608
| +372% | +$73.4K | ﹤0.01% | 4807 |
|
|
2024
Q3 | $28.2K | Buy |
13,320
+245
| +2% | +$519 | ﹤0.01% | 5137 |
|
|
2024
Q2 | $31.9K | Sell |
13,075
-58,109
| -82% | -$142K | ﹤0.01% | 5046 |
|
|
2024
Q1 | $461K | Buy |
71,184
+71,101
| +85,664% | +$461K | ﹤0.01% | 4011 |
|
|
2023
Q4 | $320 | Sell |
83
-665
| -89% | -$2.56K | ﹤0.01% | 5957 |
|
|
2023
Q3 | $1.6K | Hold |
748
| – | – | ﹤0.01% | 5622 |
|
|
2023
Q2 | $2.28K | Hold |
748
| – | – | ﹤0.01% | 5408 |
|
|
2023
Q1 | $2K | Hold |
748
| – | – | ﹤0.01% | 5551 |
|
|
2022
Q4 | $2K | Sell |
748
-752
| -50% | -$2.01K | ﹤0.01% | 5364 |
|
|
2022
Q3 | $7K | Sell |
1,500
-2,198
| -59% | -$10.3K | ﹤0.01% | 5126 |
|
|
2022
Q2 | $15K | Sell |
3,698
-11,929
| -76% | -$48.4K | ﹤0.01% | 5103 |
|
|
2022
Q1 | $68K | Sell |
15,627
-12,430
| -44% | -$54.1K | ﹤0.01% | 4898 |
|
|
2021
Q4 | $334K | Buy |
28,057
+24,209
| +629% | +$288K | ﹤0.01% | 4276 |
|
|
2021
Q3 | $66K | Sell |
3,848
-5,504
| -59% | -$94.4K | ﹤0.01% | 4871 |
|
|
2021
Q2 | $163K | Buy |
+9,352
| New | +$163K | ﹤0.01% | 4580 |
|